• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Serb`s Amversio (Betaine Anhydrous) Receives Approval in Europe

    EMA

    Soligenix Announces Strategic Partnership with SERB Pharmaceuticals

    PRNEWSWIRE

    Serb SA`s Amifampridine Serb (amifampridine) Receives Approval in Europe

    EMA

    SERB SAS` Voraxaze (glucarpidase) Receives Approval in Europe

    EMA

    SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

    PRESS RELEASE

    SERB acquires BTG to expand its treatment portfolio for unmet medical needs

    PHARMAFILE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.